Commercialization Challenges for Cell and Gene Therapies

Commercialization Challenges for Cell and Gene Therapies

07/15/2020, 10:30 AM - 12:00 PM

Innovation Stage, Booth 1281, Exhibit Hall
Language:
English
The early promise offered by cell therapies and gene therapies is tempered by the challenges associated with developing, manufacturing, and delivering the drug product to patients. The complexities of producing these therapies are testing established practices, from starting materials—to process development—to cGMP compliance—to supply chain security and reliability. This session will highlight technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization steps. The discussion will include a focus on data management and scheduling strategies to guarantee transparency and chains of authenticity and custody for personalized therapies.

Contributors

  • Feliza Mirasol

    Moderator

    Science Editor

    Pharmaceutical Technology and BioPharm International

  • Rita Peters

    Moderator

    Editorial Director

    Pharmaceutical Technology and BioPharm International

  • Amy DuRoss

    Speaker

    CEO

    Vineti

  • Alan Moore

    Speaker

    Chief Strategy Officer

    The Discovery Labs

  • Chris Murphy

    Speaker

    Vice President and General Manager, Viral Vector Services

    Thermo FISHER SCIENTIFIC

  • Alberto Santagostino

    Speaker

    Senior Vice-President, Head of Cell and Gene Therapy

    Lonza AG

    Alberto Santagostino, Head of Cell and Gene Technologies for Lonza Pharma & Biotech Alberto is Head of the Cell and Gene Technologies Business Unit...

  • Mark Sawicki, PhD

    Speaker

    Chief Commercial Officer

    Cryoport

    Mark Sawicki brings over 15 years of business development and sales management experience, having consistently delivered on corporate revenue and...

Type of Session

  1. Type of Session
    Session

Categories

  1. Track
    Keynote Series